Ohio Gov. Mike DeWine stopped by Cincinnati Children’s on Dec. 5 to announce a major boost for pediatric cancer research—a $1.48 million grant to power the ENGRAFT learning network. This collaborative effort brings together experts, families, and partners to transform outcomes for kids needing stem cell transplants, as part of a $5 million statewide investment in fighting childhood cancer.
Discover how Cincinnati Children’s uses 3D imaging to improve precision and outcomes in pediatric physeal bar excision surgery.
The new Applied Gene and Cell Therapy Center will expand capacity for manufacturing viral vectors and cell-based products under Current Good Manufacturing Practice conditions, supporting complex trials in oncology, hematology and rare genetic disorders, with capabilities for large-scale bioreactor production and post-approval therapy manufacturing.
Discover how Cincinnati Children’s CF WELL program is transforming care for children with cystic fibrosis—addressing educational and mental health needs alongside clinical advances.
User-defined virtual sensor beamforming pinpoints seizure onset zones beyond the temporal lobe, providing a solution for locating epilepsy sources other methods miss.
Researchers have achieved a breakthrough in kidney organoid development by creating early-stage plumbing that connects nephrons to waste-carrying tubules.
A Phase II clinical trial conducted in Ghana suggests that hydroxyurea — already a treatment offered for the most common form of sickle cell disease — also shows benefits for those with the hemoglobin SC (HbSC) variant of the condition.
Discover how Cincinnati Children’s experts are advancing care for complex obstructive sleep apnea through innovative nerve stimulator implants, novel evaluations, and personalized therapies.
Discover how Cincinnati Children’s multidisciplinary PUV Center is transforming care for children with posterior urethral valve disorder through collaborative, specialized treatment that improves outcomes and quality of life.
Cincinnati Children’s is advancing catheter ablation techniques to treat arrhythmias in patients with congenital heart disease.